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AIM 
 
 
1. To study the effects of renal donation on renal function in the remnant 
kidney. 
2. To study the influence of gender on renal function in kidney donors 
3. To evaluate the correlation between body mass index and renal 
function  in kidney donors. 
4. To evaluate the correlation between age and renal function in kidney 
donors. 
5. To evaluate the changes in renal size in live kidney donors 
6. To evaluate the prevalence of hypertension in live kidney donors 
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Functional Adaptation to Reduction in Renal Mass  
 
‘The renal tubules behave not as a machine failing and giving out but as a 
mechanism pushed to the limit of its capacity.’5 
Robert Platt  
Congenital absence of contralateral kidney has demonstrated that 
animals and man can lead a normal life with only one kidney. Surgical 
removal of one kidney in experimental animals and patients was performed 
in the nineteenth century and led to the observation that the remaining 
kidney subsequently undergoes compensatory growth. However, our 
understanding of the remarkable adaptive changes in structure and function 
of the kidney, after reduction in total renal mass, is the result of experimental 
studies over the past few decades. 
After the loss of renal mass, the remaining renal tissue compensates 
with an increase in growth. The rate of [14C]Choline incorporation into 
phospholipid of renal cortical slices was increased by 37% 5 min after 
surgery and persisted for at least 6 days. In addition, both the formation of 
additional cells (hyperplasia) and cellular enlargement (hypertrophy) are 
hallmarks of compensatory growth response. Alterations in DNA synthesis 
preparatory to cell division have been demonstrated within 6 hours after 
uninephrectomy and cell division reaches a peak at 2 days and again several 
  
6
days later.7, 8 An increase in RNA synthesis, used as an index of 
hypertrophy, is found within the first 12 hours and persists for weeks as 
renal mass increases. Two weeks after surgery total RNA content rises 40% 
and total DNA content by approximately 25%, showing that the predominant 
factor influencing compensatory growth is hypertrophy.8 
 An increase in the weight of the contralateral kidney in the 
uninephrectomised rat and mouse is demonstratable within 1 – 2 days after 
surgery, and growth continues until a maximum increase of approximately 
40% above control level is achieved within 1 – 2 weeks.9, 10, 11 On the basis 
of X-ray studies a marked increase in renal size also occurs in man after 
nephrectomy.12 Compensatory renal growth is initiated by loss of viable 
renal tissue and does not require surgical removal of tissue. 
 The rate of compensatory growth is stimulated by a number of factors, 
including a high- protein diet, amino acids, administration of NH4Cl, and 
several endogenous hormones.13 Conversely, starvation, protein depletion, 
and endocrine abnormalities retard growth. Galla et al. showed that the 
magnitude of compensatory growth in immature weanling rats was greater 
than in adults.14 Other studies have shown that compensatory growth is 
blunted in old animals, compared with younger adults.15 
 Studies in rats have shown that the extent of compensatory growth 
correlates closely with the amount of renal tissue that is surgically removed. 
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Kaufmann et al. compared the rate of growth in residual kidney tissue over 
4-wk interval after loss of 50% and 70% of renal mass with pair-fed 
controls.16 The weight of the remaining renal tissue increased by 81% in 
uninephrectomised animals and 168% in rats with surgical ablation of 70% 
of the initial mass, compared with an increase of 31% in controls. The 
formation of new cells, by hyperplasia corresponds in general with the 
increase in renal mass. After uninephrectomy and two- thirds nephrectomy 
there is an increase of 25% and 87% in new cell formation in the cortex of 
the contralateral and remnant kidney, respectively.17 
 Hayslett et al. determined tubular length, luminal diameter, and cell 
volume in proximal and distal convolutions from normal and unilaterally 
nephrectomised rats. There was an increase of approximately 15% in the 
luminal and external diameters of proximal tubule and a 35% increase in 
length. The distal tubule increased about 10% in diameter and 17% in 
length. Both luminal and cell volumes of proximal tubule approximately 
doubled, whereas in the distal convolution the increase was in order of 50% 
for luminal volume and 25% for cell volume.18 Oliver et al.  demonstrated 
predominance of compensatory growth in the proximal tubule convolution, 
including a marked increase in length of pars recta and loop of Henle, in 
three-quarters nephrectomised rats.19 There is experimental evidence that 
compensatory growth occurs relatively symmetrically throughout the cortex. 
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In both uninephrectomised animals and after 70% nephrectomy the 
hypertrophy index was equal in outer, middle, and deep zones of the 
cortex.20 
 Two hypotheses had been invoked to explain the phenomena of 
compensatory renal growth. The first attributes compensatory growth 
changes in the remaining kidney to the increased work load that the smaller 
renal mass is called on to perform. Studies have shown conclusively that this 
mechanism does not apply. Diversion of the urinary stream from one kidney 
into the peritoneal cavity results in a 30% increase in glomerular filtration 
rate and concomitantly in increased net reabsorption of sodium by the 
contralateral kidney. There was no evidence for an increase in renal growth 
4 days after surgery, a time interval sufficiently long to demonstrate 
compensatory growth if it were to occur.21 According to the second 
hypothesis, compensatory growth is attributed to an organ-specific humoral 
substance that may control renal mass. The role of a humoral mediator is 
supported by evidence that compensatory renal growth occurs in heterotopic 
kidney transplanted to an anephric host and in normal animals connected by 
parabiosis with an anephric partner.  
 As the population of nephrons diminishes, while the dietary intake 
and/or endogenous production of water and solutes is unchanged, there is a 
proportional increase in the excretion of water and solute by individual 
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residual nephrons. This adaptive change, which preserves zero net balance in 
the early phase of renal insufficiency, involves a reduction in the fractional 
reabsorption of substances derived from the initial glomerular ultrafiltrate 
and an increase in the rate of secretion of solutes that are extracted by 
tubular epithelial cells from peritubular blood. These compensatory changes 
are adequate to maintain electrolyte and water homeostasis until severe renal 
failure ensures (GFR < 20% of normal).22 
  
The Hyperfiltration theory 
 
Experimental studies incriminate glomerular hypertension in 
mediating progressive renal damage after any of a variety of initiating 
injuries. Glomerular hypertension and hyperfiltration occur in humans with 
diabetes mellitus, solitary or remnant kidneys, and various forms of acquired 
renal disease. Without hyperfiltration, serum creatinine levels would double 
as clearance decreases by 50% when half the total renal mass is removed. 
Brenner and colleagues proposed that maladaptive glomerular 
changes exert a major influence on the influence on the factors that initiate 
and perpetuate disease progression. These hemodynamic changes lead to 
glomerular hyperfiltration, an adaptation seen in response to a reduction in 
functional nephron number whether induced genetically, surgically, or by 
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acquired renal disease. The elevated single nephron glomerular filtration rate 
(SNGFR) common to these pathophysiologic conditions is usually caused by 
increases in glomerular capillary plasma flow rate (QA) and mean glomerular 
capillary hydraulic pressure (PGC), which in turn are due to adaptive 
reductions in preglomerular and postglomerular arteriolar resistances. 
Progressive glomerular sclerosis and proteinuria eventually occur in most 
experimental models of renal disease characterized by glomerular 
hyperfiltration and hypertension 
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Altered Glomerular hemodynamics in humans 
 
 
 
Azar et al.  and Olson et al. demonstrated  that in experimental 
hypertension, unassociated with primary renal disease, impaired 
autoregulation of renal blood flow (RBF) and glomerular flow rate (GFR) is 
decreased afferent arteriolar resistance (RA) causes hydraulically mediated 
renal damage and progressive glomerular injury.23, 24, 25 
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Experimental studies in dogs and rats with a marked reduction in renal 
mass exhibit significant loss of autoregulation of RBF and GFR in response 
to changes in renal perfusion pressure.26 
In rats with subtotal renal ablation or in uninephrectomized spontaneously 
hypertensive rats, increases in systemic pressure are transmitted directly to 
glomerular capillaries as the result of a greater reduction in RA compared 
with efferent arteriolar resistance (RE).27, 28, 29 The consequent increment in 
PGC is associated with progressive proteinuria and glomerular injury. 
The relation between intraglomerular hemodynamic abnormalities and 
progressive glomerulosclerosis in experimental renal disease is not 
straightforward. Yoshida et al. 30, 31 demonstrated that glomerulosclerosis 
correlated with glomerular hypertrophy and not PGC in a rat remnant kidney 
model. Similarly, other investigators have dissociated progression of 
experimental renal disease from increments in PGC and have suggested that 
measures of nephronal hypertrophy such as VG and RGC or the production 
of growth factors are more tightly linked to ongoing glomerular injury.32, 33, 
34, 35, 36 In this regard, mesangial cells in culture proliferate37 and produce 
excess type I and IV collagen38 in response to mechanical stretching. 
Further, both angiotensin II39, 40 and endothelin41, 42 stimulate mitogenesis of 
cultured mesangial cells. The degree of glomerular sclerosis correlates 
significantly with urinary excretion of endothelin in rats with subtotal renal 
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ablation.42 Consequently, the above data imply that in various experimental 
models renal disease progresses by different mechanisms; increments in 
PGC or VG or augmented production of angiotensin II or endothelin 
stimulate the production of growth factors that results in progressive 
glomerular obsolescence. 
The influence of hyperfiltration, the most readily monitored surrogate 
of altered glomerular hemodynamics, on renal function in humans has been 
most thoroughly evaluated in kidney transplant donors and in patients 
uninephrectomised for acquired renal disease. Even after one to two 
decades, total GFR often averages approximately 70% of prenephrectomy 
values despite the 50% reduction in renal masses, indicating that the 
remaining kidney is indeed hyperfiltering. Most studies have shown that in 
association with this hyperfilteration the prevalence of hypertension in both 
groups tends to increase after uninephrectomy, although only in transplant 
donors is hypertension apt to be more prevalent than in local, control 
populations. Similarly, the prevalence of proteinuria tends to increase in 
groups after uninephrectomy, proteinuria was shown to increase as a 
function of time after surgery. 
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Long-term effects of reduced renal mass in humans 
 
In early stages of permanent renal injury or extensive ablation, 
structural and functional adaptations associated with hypertrophy partially 
compensate for nephron losses. Glomerulotubular balance is maintained in 
these conditioned nephrons by intrinsic tubule and peritubular capillary 
adaptations that parallel single nephron glomerular filtration rate (SNGFR). 
Studies of Na+-H+ exchange in renal cortical brush border membrane 
vesicles indicate that tubule functional adaptation is not tied to loss of renal 
mass per se but rather to factors such as dietary protein content that set the 
level of SNGFR. Likewise, the structural heterogeneity that follows chronic 
renal injury or extreme ablation of renal mass is less a consequence of 
nephron injury than of adaptation linked to dietary protein intake. 
As the population of nephrons diminishes, while the dietary intake 
and/or endogenous production of water and solutes is unchanged, there is a 
proportional increase in the excretion of water and solute by individual 
residual nephrons. This adaptive change, which preserves zero net balance in 
the early phase of renal insufficiency, involves a reduction in the fractional 
reabsorption of substances derived from the initial glomerular ultrafiltrate 
and an increase in the rate of secretion of solutes that are extracted by tubular 
epithelial cells from peritubular blood. These compensatory changes are 
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adequate to maintain electrolyte and water homeostasis until severe renal 
failure ensures (GFR less than 20% of normal). After a moderate reduction 
in nephron population there is no evidence that the factors that modulate ion 
transport are qualitatively different from those that regulate renal function in 
the intact subject, when the excretory load of solute is varied by changes in 
intake or endogenous production. 
 
Long-term risks after living kidney donation 
 
Over the past four decades, the surgical technique of harvesting the 
donor kidney has been improved to such an extend that the perioperative 
mortality has been reduced to 1 out of 3000 living donor nephrectomies.43  
In the 1980s with reports of progressive hyperfiltration-mediated structural 
damage to remaining nephrons in experimental animals, there has been great 
concern and debate on the long term prognosis of kidney donors. 
Although increased long-term mortality has not been reported in 
healthy persons after nephrectomy.44, 45, 46 A survival benefit was 
demonstrated among donors in a large Norwegian series, which has been 
attributed to the rigorous evaluation and screening methods prior to renal 
donation. In a metaanalysis that took 48 studies and 5048 donors into 
evaluation, only 1 study showed 2 donor deaths due to renal failure. Seven 
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studies described cardiovascular disease in a proportion of living renal 
donors.47 
Long term effects on renal function, blood pressure, 
proteinuria/albuminuria and occurrence of ESRD has been studied in great 
detail worldwide. 
 
Renal function 
 
Accurate assessment of renal function is an essential component of 
donor evaluation. 24-hr urine collection for creatinine clearance (CCr), 
iothalamate clearance, chromium 51 – labeled ethylene diaminetetra-acetate 
(Cr51 – EDTA), measurement of cystatin C or calculated estimate using 
Cockcroft-Gault formula or the Levey formula has been used for the 
estimation of GFR.  After donor nephrectomy, serum creatinine levels 
increased by approximately 25% and creatinine clearance falls by 
approximately the same percentage.47 In a metaanalysis by Garg AX et al. an 
average decrement in GFR by 26ml/min (per 1.73m2) with the average GFR 
being 86ml/min (per 1.73m2).48 In an Indian pilot study by Sahay M et al. a 
reduction of 28.2 +/- 13.57 ml/min, a decline of GFR by 17 ml/min 
immediately post nephrectomy.49 This was followed by stabilization of GFR 
with subsequent rise by 1.4ml/ min/ decade. In reports from Sweden and the 
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United States no statistical evidence of rapid decline in GFR than the 
expected population was demonstrated.48 Several studies indicate that 
functional adaptation occurs rapidly after uninephrectomy with GFR 
remaining stable over many years. The Swiss Organ Living Donor Health 
Registry (SOL-DHR) data demonstrated a slow improvement for measures 
of serum creatinine and creatinine clearance.47 This finding is in contrast 
with the expected physiological decline in GFR associated with ageing (i.e., 
approximately 1mL/min/year). Thus, the effect of nephrectomy in terms of 
GFR by hyperfiltration outweighs the effect of normal ageing, atleast during 
the first decade. The trend beyond the first decade after nephrectomy and 
whether it may over time result in adverse changes within the remaining 
kidney has yet to be answered by long term prospective studies. 
 
Proteinuria 
 
Most progressive renal disease and all advanced glomerular diseases 
are accompanied by proteinuria and albuminuria. Albumin has been 
suggested as the better variable for follow up in donor nephrectomies as it is 
a single, relatively small protein, which can be measured fairly accurately 
and the earliest to appear in urine in the setting of renal damage. Slight 
increase of glomerular intracapillary pressure or minimal ‘glomerular 
  
18
hypertension’ is expected in post nephrectomy patients. As glomerular 
injury progresses, systemic and glomerular hypertension may worsen and 
accelerate renal damage. Since microalbuminuria is a sign of glomerular 
injury, its recognition and treatment are important if progressive damage is 
to be avoided. 
Garg AX et al. in his metaanalysis showed an incidence of proteinuria 
in 42 studies to be ranging from less than 5% to 20%.48 The pooled incidence 
of proteinuria among 9 studies which quantified the proteinuria in a total of 
1799 donors for 7 years was 10%. There was a statistically significant 
increase in 24-hr urine protein in donors when compared to controls an 
average of 11 years postnephrectomy.49 In two of the studies, 24-hr urine 
albumin was found to be 56 mg higher in donors compared to controls 14 
years after donation. The pooled risk of microalbuminuria after kidney 
donation was 3.9.  
Statistically significant development of proteinuria in post 
nephrectomy patients where reported by Sahay et al. 40% of the population 
in study developed microalbuminuria and 14% developed overt 
proteinuria.49 In a study by Fehrman-Ekholm et al. demonstrated that donors 
with proteinuria were more prone to hypertension and had lower GFR than 
donors without proteinuria. Data from a number of studies appear to indicate 
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a significant increase in development of proteinuria in donors when 
compared to the general population. 
In Switzerland, donors who develop albuminuria are advised to 
consult their family physicians for the initiation of renoprotective drugs such 
as ACEIs and ARBs.  
 
Hypertension 
 
Hypertension remains an issue of concern in kidney donors as it may 
initiate or accelerate nephrosclerosis and renal failure in the normal solitary 
kidney. Renal reserve is reduced even if serum creatinine is within normal 
levels.50 Most investigators have reported hypertension in 17 – 33% of 
former donors. When these results were compared with age-matched general 
population there was no significant incidence of hypertension.51, 52, 53, 54 In a 
metaanalysis of all studies comprising more than 3100 nephrectomised 
patients and 1700 appropriate controls, no increment in incidence of 
hypertension was found. However, there was an average increase in blood 
pressure of 2 – 3 mmHg and a further increase in systolic pressure of 1mm 
Hg for each decade following kidney ablation. In Sahay M et al. study a 
statistically significant 9.96 mm Hg rise in mean arterial pressure was 
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reported.49 All donors with a family history of hypertension became 
hypertensive post nephrectomy.  
 
Occurrence of End Stage Renal Disease in Donors 
 
Functional and anatomical adaptation to reduction renal mass is 
achieved by the remaining nephrons, unlike living liver donation where liver 
regeneration occurs up to 80%. Studies in experimental model have 
demonstrated hyperfiltration, albuminuria and ultimately renal insufficiency 
following ablation of renal mass. It is possible that similar events may occur 
in human kidney donors. 
Adaptive hyperfiltration has found to stabilize the clearance at 70 – 
80% of pre-donation values in many studies. Albuminuria the earliest 
indicator of glomerular hypertension reflects the changes in selectivity of 
glomerular permeability, ultimately resulting in injury. Continuous renal 
insult leads to slow attrition of nephron numbers, commonly termed 
‘hyperfiltration injury’ leading to focal and then global glomerulosclerosis in 
the remnant kidney. 
In 2002, United Network for Organ Sharing (UNOS) database 
analysis of 47996 living donors showed that 20 donors had been listed for 
cadaveric kidney transplantation. Another 36 donors had been transplanted 
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before UNOS was started in 1987. Interestingly 85% of the subjects had 
donated to a sibling, indicating the possibility of a genetic predisposition to 
kidney disease. The time from donation to ESRD in these subjects ranged 
from 2 to 31 years.55 Hypertensive nephrosclerosis, focal glomerulosclerosis 
and chronic glomerulonephritis accounted for two-thirds of diagnoses 
leading to ESRD. In Garg AX et al metaanalysis, a total of 10 donors from 
eight different studies were living with kidney failure at the time of late 
assessment.48 In a case series from Chennai by Prakash KC, a total of ten 
renal donors who developed renal complications were seen. Three donors 
had acute renal failure with complete recovery of renal functions. Two 
donors had nephrotic syndrome of which one responded completely to a 
short course of steroids. Five donors developed chronic renal failure (One 
was on dialysis support, one underwent renal transplantation and three are 
on conservative management).56 
Current data are inconclusive but might be interpreted to indicate that 
the occurrence of ESRD is higher after living donor nephrectomy than in the 
general population. However, since most of the donors are relatives of 
someone with kidney diseases, the actual increment in risk may be difficult 
to calculate. 
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Additional studies and lengthier follow-up using the existing 
databases will be necessary to be able to provide accurate information about 
the risk of developing ESRD to prospective donors. 
The currently available data indicate that long-term health risks 
associated with donor nephrectomy are quite low. Donors should be 
rigorously evaluated before the nephrectomy and followed up frequently to 
detect changes in blood pressure, albumin excretion and renal function. 
Early detection and appropriate medical or surgical intervention is of utmost 
importance as it generally gives the best chance for preventing deterioration 
in health or ESRD. 
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MATERIALS AND METHODS 
SETTING 
 A retrospective cohort study and analysis of patients drawn from 
Nephrology Clinic in Government Kilpauk Medical College,Kilpauk 
and Government General Hospital, Chennai. 
STUDY POPULATION 
 The study was conducted over a 12 month period from June 2006 
to June 2007. Cases were drawn from Nephrology clinic, Department of 
Nephrology, Kilpauk Medical College and Govt. General Hospital, 
Chennai. Informed consent was taken from all participants of the study. 
A total of fifty-three patients were randomly chosen at the start of the 
study.  Ten patients were excluded from study, as they were not willing 
for any investigations. Five patients were omitted as they were not able 
to provide pretransplantation records and details. Five patients did not 
report after basic renal blood and urine investigations.  
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INCLUSION CRITERIA 
 
All live kidney donors 
 
 
EXCLUSION CRITERIA 
 
• Patients unwilling for investigations 
• Patients allergic to nuclear tracer drugs 
• Patients with recent history suggestive of ARF 
• Patients with CCF 
• Patients with known congenital renal diseases (viz., Polycystic 
kidney disease, Alport’s disease, etc) 
• Patients on long term use of analgesics 
• Patients who are known diabetics/HbsAg/HIV 
Information was collected as per the Performa (Appendix I), 
consisted of basic data, including name, sex, age and occupation. All 
patients were from low socio-economic groups according to 
Kuppuswamy Scale.57 Detailed history pertaining to symptoms 
suggestive of renal failure, ischemic heart disease and renal stone 
disease was recorded from the patients. Patients were enquired regarding 
the usage of antihypertensive drugs or any other medications. 
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 Anthropometric measurements including height in metres 
(standing height using stadiometer) and weight in kilograms were 
measured. 
 Vitals were recorded. Blood pressure was recorded at three 
occasions during the course of the study. 
Detailed clinical examination of all systems was carried out to rule out 
any associated disease state. 
 Predonation random blood sugar, blood urea, serum creatinine, 
serum electrolytes and ultrasound measurements were recorded from the 
donors previous records.  
 The donors underwent serum random blood sugar, blood urea, 
serum creatinine and serum electrolytes measurement. The post 
donation glomerular filtration rate was calculated using these data 
according to the Cockcroft Gault and MDRD (IV) formulae. The 
measurement of the undonated kidney was performed using 
ultrasonography. The donors were then taken up for 99mTc DTPA Renal 
Scintigraphy for estimation of glomerular filtration rate.  
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REFERENCE VALUES USED IN THIS STUDY 
BMI (WHO criteria for Asian population)58 
Body Mass Index = Weight (kg) / Height (m)2  
Values  18.5 -22.9 kg/m2 was taken as normal weight 
   23 – 29.9 kg/m2 was taken as overweight 
   ≥ 30 kg/m2 was taken as obesity 
BODY SURFACE AREA (BSA) 
The Mosteller formula was used for calculation of body surface area59  
BSA (m²) = ( [Height(cm) x Weight(kg) ]/ 3600 )½ 
 
STAGING OF HYPERTENSION (According to JNC VII)(102) 
Classification Systolic BP  (in mmHg) Diastolic BP  (in mmHg)
Normal < 120 < 80 
Pre-hypertension 120 – 139 80 – 89 
Stage I 140 – 159 90 – 99 
Stage II ≥ 160 ≥ 100 
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BLOOD SUGAR 
 Fasting Glucose ≥ 126 mg % and random blood sugar ≥ 200 mg% 
patients with symptoms were taken as diabetes. Such patients were 
excluded from the study.. 
BLOOD UREA 
The Blood urea in this study was estimated using DAM method 
(Diacetyl  Monoxime). The normal value which being 20 – 40 mg%. 
SERUM CREATININE  
 Serum creatinine was estimated using Modified Jaffe’s method. 
Values of >1.5mg%60 in males and females were suggestive of renal 
impairment. 
SERUM ELECTROLYTES 
 Serum sodium and potassium were measured using flame 
spectrometric method. Serum sodium values of 136 – 145 meq/L were 
considered to be within the normal range. Serum potassium values of 
3.5 – 5 meq/L were considered within normal range.  
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ULTRASONOGRAPHY 
 The kidneys were visualized using a Larsen Tourbo Ltd. Sonata 
Plus Ultrasonogram in GKMCH Department of Radiology and 
measurements taken as accurately as possible. 
99mTc DTPA RENAL SCINTIGRAPHY 
Renal Scintiscan was performed after i.v injection of 5.0 mCi 
99mTc – DTPA. Early dynamic images were acquired for 1 minute and 
delayed static images were acquired after 20 minutes. 20mg Furosemide 
i.v was administered along with the activity – (F + 0) protocol. The 
images were then processed using the GATES algorithm. 
STAGES OF CHRONIC KIDNEY DISEASE 61 
Stage Description GFR (ml/min/1.73m2) 
1 Kidney damage with normal or ↑ GFR >90 
2 Kidney damage with mild ↓ GFR 60-89 
3 Moderate ↓ GFR 30-59 
4 Severe ↓ GFR 15-29 
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DISCUSSION 
 
In this study, done among 30 renal donors the mean age of the renal 
donors at evaluation was 41.7 yrs ± 7.535 (Mean ± S.D). In comparison to 
many of the other studies this study has a younger population. 
 
Study Mean Range 
This study 41.7 yrs ± 7.535 27 – 58 
Saran R et al. 62 64 yrs ± 9 38 – 80 
Talseth T et al. 63 56 yrs  42 – 66 
Grossmann J et al. 64 57 yrs ± 11 NA 
 
Although older age at the time of donation was associated with lower 
pre- and post donation GFR, no statistical association between change in 
GFR after donation and age at the time of donation was reported by AX 
Garg et al..48 A significant association was demonstrated between fall in 
GFR and age of donors at nephrectomy in this study. The mean age of the 
donors at donation in this study was 37.1 yrs ± 8.932 (Mean ± S.D). This 
study constituted of a population younger than other studies under 
comparison. 
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Study Mean Range 
This study 37.1 yrs ± 8.932 20 – 55 
Talseth T et al. 63 46 yrs  33 – 55 
Grossmann J et al. 64 45 yrs ± 11 NA 
Sahay M et al.49 41 yrs ± 8.12 25 – 54.16 
 
The gender distribution demonstrated a majority of 80% female 
donors compared to a 20% donation by the opposite sex. 
 
Study Males Females 
This study 20 80 
Saran R et al.57 49 51 
Grossmann J et al.59 29 71 
Sahay M et al.49 56 44 
 
In comparison to western studies, in which the mean duration 
following donation was greater than a decade, this study had shorter duration 
of follow-up. The mean duration since nephrectomy was 4.69 yrs +/- 4.288 
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(Mean ± S.D). The mean follow-up duration of this study was similar to the 
pilot study conducted in Hyderabad.49 
 
Study Mean Range 
This study 4.69 yrs ± 4.288 0.6 – 15 
Saran R et al. 19.6 yrs ± 5.0 NA 
Talseth T et al. 11 9.9 – 12.25 
Grossmann J et al. 11 yrs ± 7 1 – 28 
Sahay M et al. 5.25 NA 
 
Praga M et al. demonstrated renal insufficiency after renal donation in 
92% of donors with BMI >30kg/m2 at the time of nephrectomy. Multiple 
logistic regression analysis showed the risk of developing renal disease 
statistically correlated with BMI at the time of nephrectomy.65 In comparison 
to Grossmann et al., whose mean BMI was 26 ± 4; this study had a lower 
BMI of 24.84 kg/m2 ± 4.024. 
Goldfarb et al. reported a higher serum creatinine after donation for 
males but no difference in GFR.66 A similar result was obtained in this 
study. A significantly higher serum creatinine was observed in males 
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compared to females while no difference was noted between the genders and 
post donation GFR. 
The minimal data regarding human glomerular hemodynamics 
suggest that reduced pre-glomerular vascular resistance to be responsible for 
the hyperfiltration that occurs after nephrectomy.67, 68 Without 
hyperfiltration, serum creatinine would double as GFR decreases by 50% 
when half the total renal mass is removed. After donor nephrectomy, serum 
creatinine levels increase by approximately 25% and GFR falls by 
approximately the same percentage.47 The Swiss Organ Living Donor Health 
Registry (SOL-DHR) data indicate a slow improvement for measures of 
serum creatinine and GFR. In a meta-analysis by AX Garg et al., the average 
serum creatinine before and at follow-up was 0.92mg/d and 1.11mg/dl 
respectively.48 In this study the rise in serum creatinine was observed to be 
16% and the reduction in GFR (estimated by MDRD formula) to be 
approximately 17%. The result that there is a statistically significant increase 
in serum creatinine following kidney donation was corroborates with the 
findings of Grossmann et al. 64 
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Study Predonation  S. Creatinine Post donation Significance 
This study 0.915 mg/dl ± 0.073 1.069 ± 0.284 P = 0.0065 
Sahay M et al. 0.97 ± 0.09 mg/dl 1.22 ± 0.82 Ns 
Talseth T et al. 79 µmol/l 88 NA 
Grossman J et al. 72.5 ± 15 µmol/l 85.7 ± 16.8 P < 0.001 
 
Sahay M et al., studied donor sex influence on renal function and 
demonstrated a significantly greater degree of hypertrophy in males as 
compared to females. Although females were observed to have greater 
degree of hypertrophy in comparison to males (7% vs 5%), the increase was 
not found to be statistically significant according to this study. There was a 
statistically significant increase in the renal length and width of the remnant 
kidney, which corroborated with Sahay M et al. study.49 
 
Study Predonation  Kidney length Post donation Significance 
This study 9.804 10.536 P < 0.001 
Sahay M et al. 9.46 ± 0.39 10.60 ± 0.73 P < 0.05 
 
A meta-analysis by AX Garg et al., the mean GFR before 
nephrectomy and at follow up was 111ml/min and 86 ml/min, respectively.48 
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A meta-analysis by Kasike et al. showed a decline of GFR by 17ml/min 
immediately post nephrectomy.69 This was followed by stabilization of GFR 
with subsequent rise by 1.4ml/min/decade. The Swiss Organ Living Donor 
Health Registry (SOL-DHR) data also demonstrated a slow improvement for 
measures of serum creatinine and GFR. This finding is in contrast with the 
expected physiological decline in GFR associated with ageing (i.e., 
approximately 1ml/min/year). Thus, the effect of nephrectomy in terms of 
increasing GFR by hyperfiltration outweighs the effect of normal renal 
ageing, at least during the first decade. The as-yet-unanswered questions are 
whether this trend will continue beyond the first decade after nephrectomy 
and whether it may, over time, result in adverse changes within the 
remaining kidney. There is however data from Sweden and Cleveland that 
demonstrated no significant fall in GFR and a stabilization of GFR to 
approximately 72% of predonation levels at least 25 years after donation.66, 
70 The solution to such unanswered questions lies in prospective data 
collection or registries and long-term studies (including patients beyond 40 
years postnephrectomy). 
In studies by Saran R et al. and Goldfarb DA et al., although women 
were reported to have lower GFR both before and after donation when 
compared to men, no statistically significant gender difference in decrement 
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in GFR after donation was observed in this study.62, 66 Elderly donors 
demonstrated a lower GFR both before and after donation; the decrement in 
GFR after donation, however, tended to be smaller, larger or no different 
than younger individuals in many studies. Although Gracida et al. reported 
predonation obesity not to be associated with post-donation GFR; Praga et al 
reported statistical correlation between developing renal disease and BMI at 
the time of nephrectomy. 65, 71 The time after donation was not associated 
with post-donation GFR or change in GFR in this study. In an isolated study, 
a higher drop in GFR was associated with higher pre-donation blood 
pressure 63 and higher predonation GFR.64 The latter observation was 
explained by Talseth T et al as a regression towards the mean rather than a 
true reduction in renal function.  
A statistical significant reduction in GFR (calculated by MDRD) after 
nephrectomy was demonstrated in this study. In this study statistically 
significant association was established between fall in GFR and age at 
donation, gender, body mass index, body surface area and predonation GFR. 
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Study 
Predonation GFR 
(MDRD) 
Postdonation 
GFR 
Significance
This study 80.367 ± 15.343 66.533 ± 17.797 0.0012 
Grossmann et al. 92 ± 20 71 ± 15 P <0.001 
 
The development of hypertension following kidney donation was 
found to statistically significant in this study like in other studies like 
Grossmann et al. and Sahay M et al.49,64 
 
Study Predonation incidence of HT Post donation Significance
This study 0% 33% P < 0.001 
Talseth T et al. 10.29% 14% Ns 
Grossman J et al. 7% 30% P < 0.001 
Goldfarb et al. 0% 48% P < 0.001 
Sahay M et al. 0.5% 46% P <0.05 
 
Most authors have reported an increased prevalence of hypertension 
(4% to 31%) in kidney donors. Although many studies found statistically 
significant increase in prevalence of hypertension following donation, this 
association was found not statistically significant when compared to an age 
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matched population. This could be explained by the tendency of the human 
hemodynamics to develop hypertension with aging. Further more, the 
increase in systolic blood pressure seen in donors older than 50 years likely 
reflects the age related increase in blood pressure noted in the general 
population. 66 
Grossmann et al. reported a negative correlation between blood 
pressures at the time of donation and increase in blood pressure over time, 
i.e., the lower BP at the time of donation, the larger the increase over time. 64 
Talseth et al., reported a positive correlation between pre-operative and 
follow-up blood pressure and suggested that the relatively depressed GFR 
contributed to the increase in BP postoperatively.63 Similarly, Eberhard et al. 
in a study of 29 donors found hypertension in 29% at 11.3 +/- 8 years of 
follow up.72 In contrast to the above studies, Mayo Clinic reported no 
adverse effects on blood pressure in 24 mildly hypertensive donors 1 year 
after donation.73 The prevalence of hypertension was not found to be higher 
than the general population by Grossmann et al..64 Sahay M et al. 
demonstrated 46% of the study population to be hypertensive after 
nephrectomy.49 Although Talseth et al. reported statistically significant 
increase in both systolic and diastolic blood pressure, Sahay M et al found 
this observation to be statistically insignificant in their study.49, 63 Torres et 
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al. opinioned that the increased risk for hypertension was due to familial 
genetic factors predisposing them to hypertension or renal disease, which 
was proven by the demonstration of hypertension in all donors with a family 
history by Sahay M et al..52 
In this study a 33% prevalence of hypertension was noted following 
donation, which was found to be statistically significant. No significant 
association was noted between hypertension and gender, postdonation 
period, reduction in GFR and body mass index. Body surface area and age at 
donation was found have significant association with the development of 
hypertension following donation.  
The exact number of donors who develop ESRD is unknown, but the 
incidence appears to be quite low. Several studies show incidence of ESRD 
to range from 0.04% to 0.64%.55, 70, 73, 74 Current data are inconclusive but 
might be interpreted to indicate that the occurrence of ESRD is higher after 
living donor nephrectomy than in the general population. In this study only 
one patient was seen to be in stage 4 chronic kidney disease.  
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CONCLUSION 
 
In this study, the significant changes in renal size, serum creatinine, 
glomerular filtration rate and prevalence of hypertension shows that Indian 
kidney donors do not behave any differently from their Western 
counterparts. Untreated hypertension is a known risk factor for 
nephrosclerosis and renal failure in the general population. It seems logical 
that the solitary kidney has enhanced risk and the glomeruli are exposed to 
greater systolic blood pressures than those of hypertensives with two 
kidneys. Since hypertension is one of the root causes for many adverse 
consequences affecting many organs including the kidney, aggressive 
screening and treatment is indicated. A complete disclosure of all possible 
short-term and long-term complications after renal donation should be made 
to every potential donor. 
 
Although currently available data from numerous studies indicate that 
long-term health risks associated with donor nephrectomy are quite low, 
arguments for and against organ donation by living have remained for many 
years because of insufficient thoroughly evaluated data through lack of 
prospective studies. This is at least partially a direct consequence of using 
 66
only healthy persons as donors, and it seems important going forward to 
preserve this precedent. 
 
This study has shown a significant association between age and serum 
creatinine at the time of donation and the reduction in glomerular filtration 
rate. Although no criteria can accurately predict pre-operatively which donor 
will need medical care and treatment after nephrectomy, the use of fixed cut-
off points for donor acceptance, such as age, glomerular filtration rate and 
blood pressure can help in selection till concrete evidence-based protocols, 
drawn from long-term prospective studies, for donor selection is made. 
 
Since a renal donor logically conforms to the definition of chronic 
kidney disease a stage-wise approach for the treatment of donors is essential.  
The key to a healthy donor in the long run at present lies with strict rigorous 
screening of donors and strict adherence to “The Consensus Statement of the 
Amsterdam Forum on the Care of the Live Kidney Donor”.75 
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Name        Age 
Sex        Occupation 
Income      No. of family members(family size) 
Per capita income 
 
History 
Year of donation of kidney 
Donated to 
C/o pedal edema 
C/o facial puffiness 
C/o dec. urinary output 
C/o burning micturition 
C/o loin pain/stones in urine 
C/o chest pain/palpitation/dyspnoea/syncope 
C/o fever in recent past 
H/o diabetes/hypertension/prolonged drug use 
 
O/E 
Built – Poor / Moderately / Well  
Nourished – Emaciated / Poor / Moderately / Well / Obese 
Wt.      Ht. 
Pallor / Icterus / Clubbing / Cyanosis / Lymphadenopathy / Pedal edema 
Pulse        BP 
Febrile 
 
RS – NAD / Creps 
 
CVS – NAD / Murmurs 
 
P/A – Abdomen – Distended / Scaphoid 
 Free fluid 
 Spleenomegaly / Hepatomegaly 
 Renal Bruit 
 
CNS – NFND 
 
Inv. 
 Pre transplantation Post transplantation 
RBS   
B.Urea   
S.Creatinine   
S. Electrolytes Na/K   
Urine routine   
USG Abdomen   
DTPA GFR   
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RESULTS 
• The Study included 6 males and 24 females.  
• In this study the age of the renal donors ranged from 27 to 58 yrs and 
the age of the renal donors at the time of donation ranged from 20 to 
55 yrs.  
• The most common recipient of the kidney was the son. 
• The study included a majority of 26 patients in their first decade after 
donation and 4 patients in their second decade after donation. 
• 4 patients in the study were found to be obese. 
• The number of donors on antihypertensive drugs was 4 and the 
number of newly detected hypertensives was 6.Therefore, 10 patients 
out of 30 patients developed hypertension following renal donation. 
• 6 patients had predonation GFR greater than 90ml/min/1.73m2 body 
surface area while the majority had their predonation GFR between 60 
and 89ml/min/1.73m2. 
• 24 patients developed a reduction in GFR as calculated by the MDRD 
formula, 4 had an increase in GFR and 2 had no change in GFR. 
• 1 patient was under conservative management for renal failure 
following donation after 9 years. 
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• 28 donors underwent the Technetium99 DTPA scan for GFR 
estimation, 2 donors were unwilling to have the investigation 
performed.  
 
Age-wise distribution of donors 
Age Group Donors 
20 - 34 4 
35 - 49 22 
50 - 64 4 
 
 
0
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donors
20 -34 35-49 50-64
Age distribution
Age distribution
Donors
 
The mean age of renal donors was 41.7yrs ± 2.69 (Mean ± Confidence 
Interval). 
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Age-wise distribution of donors at the time of donation 
 
Age Group Donors 
20 - 34 10 
35 - 49 17 
50 - 64 3 
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The mean of age at which donors donated their kidney was 37.1yrs ± 
3.20 
 
 
 
 
 
Sex Mean age Mean age at donation 
Male 41.7 ± 6.029 37.067 ± 7.147 
Female 41.58 ± 2.729 37.417 ± 3.218 
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 Gender Distibution 
 
Gender Donors 
Females 24 
Males 6 
 
 
Gender distribution
Females
Males
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Distribution of recipients 
 
Recipients Number
Father 1 
Husband 3 
Son 10 
Daughter 4 
Mother 1 
Unknown 1 
Others 10 
 
Distribution of recepients to whom donors 
donated their kidney
Father
Husband
Son
Daughter
Mother
Unknown
Others
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Distribution of Postdonation duration  
 
Post donation 
duration Donors 
< 5 yrs 20 
5 - 10 yrs 6 
>10 yrs 4 
 
The post donation period ranging from .6 – 15yrs.The mean of which 
being 4.69 yrs ± 1.54 (Mean ± CI). 
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Distribution of Weight and Height in Donors 
 
The average weight of the donors was 59.67 ± 3.75 kg (Mean ± CI). 
The average height of the donors was 154.97 ± 2.36 cm (Mean ± CI). 
The average BSA of the donors was 1.59 +/- 0.05 (Mean ± CI). 
 
Distribution of BMI in Renal donors 
 
BMI Number 
<18.5 1 
18.5 - 24.9 17 
25 - 29.9 8 
>30.0 4 
 
BMI distribution
<18.5
18.5-24.9
25 - 29.9
>30.0
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The average BMI of the donors was 24.84  ± 1.44 kg/m2 (Mean ± CI). 
 
Distribution of Blood Urea in Donors Before and After donation 
 
The average Predonation Urea was 23.96 mg% ± 1.04 and the mean 
Postdonation Urea was 29.48 mg% ± 2.91 (Mean ± CI).. 
 
 N Mean 
95% of Lower 
Confidence Limit (LCL) 
of mean 
95% of Upper 
Confidence Limit (UCL) 
of mean 
Predonation 
Urea 
10 23.96 22.893 25.026 
Postdonation 
Urea 
20 29.48 26.447 32.513 
P=0.000543 
A statistically significant elevation in blood urea levels was observed 
following donation of kidney (p <0.01) on analysis with paired t test. 
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Distribution of Serum Creatinine in donors before and after donation 
 
The mean Predonation Creatinine was 0.92 mg% ± 0.03 and the mean 
Postdonation Creatinine was 1.07 mg% ± 0.03 (Mean ± CI). An increase of 
16% in serum creatinine was noted following renal donation over a mean 
follow up period of 4.69 years. 
 N Mean 95% of LCL of mean 95% of UCL of mean 
Predonation Creatinine 30 0.915 0.888 0.942 
Postdonation Creatinine 30 1.0693 0.9632 1.175 
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There was statistically significant elevation of serum creatinine in 
patient following the donation of kidney (p= 0.0065) as analyzed by paired t 
test. 
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Distribution of Renal length and width assessed by USG 
 
In my study, predonation data of 2 patients pertaining to kidney size 
was not available due to the unavailability of infrastructure at the time of 
transplantation. The mean predonation ultrasound length of the remnant 
kidney of the remaining 28 patients was 9.8 cm ± 0.3 (Mean ± CI).and the 
mean predonation ultrasound width of the remnant kidney was 3.82 cm ± 0.2 
(Mean ± CI). 
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The mean postdonation ultrasound length of the kidney was 10.66 cm 
± 0.26 and the mean postdonation ultrasound width of the kidney was 4.46 
cm  ± 0.21. 
 
 N Mean 95% LCL of Mean 95% UCL of Mean 
Predonation Length 28 9.804 9.491 10.116 
Postdonation Length 28 10.536 10.322 10.749 
P=0.000413 
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 N Mean 95% LCL of Mean 95% UCL of Mean 
Predonation Width 28 3.821 3.616 4.027 
Postdonation Width 28 4.426 4.206 4.646 
P=0.00067 
A statistically significant increase in both renal length and width as 
evidenced by ultrasonography was observed following donation of kidney 
(p<0.0001). 
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Distribution of GFR prior to renal donation 
 
Predonation GFR using 
MDRD Formula 
Number of 
Donors 
>90 6 
60 – 89 24 
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The mean Predonation GFR using the MDRD formula was 80.37 
ml/min/1.73m2 ± 5.9 (Mean ± CI). 
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Distribution of Postdonation GFR 
 
GFR Post renal donation 
CKD Stages 
MDRD CDTPA CGF 
>90 1 2 8 
60 - 89 19 9 11 
30 - 59 10 16 11 
15 - 29 0 1 0 
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In this study, 2 of  patients refrained from performing the DTPA test. 
The mean postdonation GFR estimated by Tc99 DTPA and corrected to 1.73 
m2 of body surface area of the remainder 28 patients was 57.78 
ml/min/1.73m2 ± 6.45 (Mean ± CI). 
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The mean postdonation kidney area as calculated by the Tc99 DTPA 
GFR estimation was 70.66 cm2 ± 3.01 (Mean ± CI). 
The mean perfusion index was 162.97 ± 30.7 (Mean ± CI). 
The mean postdonation GFR calculated by Cockcroft Gault Formula 
was 72.18 ml/min/1.73 m2  ± 7.79 (Mean ± CI). 
The mean postdonation GFR calculated by MDRD Formula was 
66.53 ml/min/1.73 m2  ± 6.37 (Mean ± CI), which was observed to be 
82.78% of the predonation GFR. 
The mean reduction in GFR (calculated as per the MDRD formula) 
following renal donation was 14.17 ml/min/1.73m2  ±  7.61 (Mean ± CI). 
 
 N Mean 95% LCL of Mean 95% UCL of Mean 
Predonation GFR 30 80.367 74.637 86.096 
Postdonation GFR 30 66.533 59.888 73.179 
P=0.0012 
The reduction in GFR following renal donation was found to be 
statistically significant on application of student’s paired t test (p=0.0012). 
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Long-term outcomes of Renal donation 
 
Reduction in GFR 
 
Fall in GFR and Age at donation 
 N Mean 95% LCL of Mean 95% UCL of Mean 
Age at the time of donation 30 37.067 33.731 40.402 
Fall in GFR 30 -14.167 -22.114 -6.219 
P<0.001 
 The fall in GFR was found to be statistically significant as the age at 
donation increased. (p<0.001) 
 
Fall in GFR and Gender 
 
Gender N Mean 95% LCL of Mean 95% UCL of Mean 
Female 24 -7.542 -13.256 -1.827 
Male 6 -40.667 -69.049 -12.284 
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 A statistically significant fall in GFR was noted among males in 
comparison to females (p<0.001) when analysed using student’s t test. 
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Fall in GFR and BMI 
 
 N Mean 95% LCL of Mean 95% UCL of Mean
BMI 30 24.843 23.341 26.346 
Fall in GFR 30 -14.167 -22.114 -6.219 
P<0.001 
 An increase in BMI was associated with a statistically significant 
reduction in GFR (p<0.001). 
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Fall in GFR and BSA 
 
 N Mean 95% LCL of Mean 95% UCL of Mean
BMI 30 24.843 23.341 26.346 
Fall in GFR 30 -14.167 -22.114 -6.219 
  
A statistically significant correlation was noted between reduction in 
GFR and body mass index (p<0.0001). 
 
Fall in GFR and Predonation GFR 
 
 N Mean 95% LCL of Mean 95% UCL of Mean
Predonation GFR 30 80.367 74.637 86.096 
Fall in GFR 30 -14.167 -22.114 -6.219 
P<0.0001 
There is a statistically significant correlation between predonation 
GFR and reduction in GFR (p<0.0001) on application of students t test. 
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Hypertension 
The number of donors on antihypertensive drugs was 4 and the 
number of newly detected hypertensives was 6. Therefore, 10 patients out of 
the sample population was hypertensive following renal donation. 
 
Prevalence of Hypertensives in Renal Donors
HTN
Non HTN
 
There was a 33% increased incidence of hypertension in patients 
following renal donation, which was found to be statistical significant (p < 
0.00001). 
 
Age group No. of Hypertensives No. of Non-hypertensives % of hypertensives
35 – 49 7 15 31.8 
50 – 64 3 1 75 
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 Hypertensive
Non 
Hypertensive 
Total 
35 – 49 yrs 21% 79% Chennai 
Population 50 – 64 yrs 38.4% 86.6% 
100% 
35 – 49 yrs 31.8% 68.2% Donated 
Population 50 – 64 yrs 75% 25% 
100% 
 
When the above-mentioned population was age-matched with data 
from Dr V Mohan’s CURES study (n = 2350), which investigated the 
prevalence of hypertension in Urban Chennai population statistical 
significant prevalence of hypertension was demonstrated only in the age 
group between 50 – 64 yrs (p < 0.0001, RR = 1.953). In the age group 
between 35 – 49 yrs, although a 1.54 times increased risk of development of 
hypertension was demonstrated in nephrectomised patients compared to the 
normal population, no statistical significance was noted (p = 0.1160). 
 
Hypertension and Gender 
Gender was not found to be a factor affecting development of 
hypertension in renal donation patients. The Fischer exact test was 
statistically insignificant (p= 0.1413) 
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Sex Hypertensive Non Hypertensive Total 
Female 6 18 24 
Male 4 2 6 
Total 10 20 30 
 
Age and Hypertension 
 
The mean age of patients who were hypertensive was 42.2yrs and a 
statistically significant correlation between age at donation and development 
of hypertension was seen in donors (p=0.023197).  
 
95% C.I 
 N Mean 
LCL UCL 
Hypertensive 10 42.2 35.6215 48.79785 
Nonhypertensive 20 34.5 30.85416 38.14384 
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Hypertension and Postdonation period 
 
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% of LCL 
of Mean 
95% of UCL of 
Mean 
Hypertensive 10 5 4.643 1.468 1.679 8.321 
Nonhypertensive 20 4.54 4.217 0.943 2.566 6.513 
 
No statistically significant correlation was found between the 
development of hypertension and the postdonation duration (p=0.787222). 
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Body Mass Index and Hypertension 
 
 N Mean 95% of LCL of mean 95% of UCL of mean
Hypertensive 10 26.3 22.429 30.171 
Nonhypertensive 20 24.12 22.698 25.532 
P= 0.165 
There was no statistically significant correlation observed between the 
development of hypertension and the BMI of the patients (p=0.165) on 
application of student’s t test. 
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Body Surface Area and hypertension 
 
 N Mean 95% of LCL of mean 95% of UCL of mean
Hypertensive 10 1.659 1.562 1.755 
Nonhypertensive 20 1.55 1.490 1.609 
P= 0.038 
Statistically significant correlation was observed between Body 
surface area and the development of hypertension (p=0.038) on application 
of student’s t test. 
 
Reduction in GFR and hypertension 
 
 N Mean 95% LCL of Mean 95% UCL of Mean 
Hypertensive 10 -23.8 -37.662 -9.9377 
Nonhypertensive 20 -9.35 -19.170 0.470 
P=0.0792 
Although hypertensive patients had a greater reduction in GFR 
compared to their nonhypertensive controls, this difference was not found to 
be statistically significant (p=0.0792). 
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Hypertension and Postdonation GFR 
 
 N Mean 95% LCL of Mean 95% UCL of Mean 
Hypertensive 10 56.5 42.344 70.656 
Nonhypertensive 20 71.55 64.632 78.468 
P=0.0262 
    
A statistically significant correlation was observed between 
hypertension and postdonation GFR(p=0.0262). 
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Comparison of GFR by using different formula in patients with single 
kidney 
 
GFR N Mean Standard Error 
GFR by Cockcroft Gault Formula 28 70.493 3.53 
GFR by MDRD Formula 28 64.643 3.53 
GFR estimated by 99mTc DTPA 28 57.779 3.53 
P= 0.043882 
A statistically significant difference was established between 3 
methods of calculation of GFR on analysis with Repeated measures Analysis 
of Variance (p= 0.0439). 
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KEY 
• S. No. – Serial Number 
• AHTN Drugs – Antihypertensive drug therapy 
• Wt. – Weight (in kilograms) 
• Ht. – Height (in centimeters) 
• BMI – Body Mass index (in kg/m2) 
• BSA – Body Surface Area (in m2) 
• SBP – Systolic Blood Pressure (in mm of Hg) 
• DBP – Diastolic Blood Pressure (in mm of Hg) 
• B. Urea – Blood Urea (in mg%) 
• S. Cr. – Serum Creatinine (in mg%) 
• USG L – Ultrasound length of kidney (in centimeters) 
• USG W – Ultrasound width of kidney (in centimeters) 
• GFR MDRD – Glomerular Filtration Rate estimated by MDRD (IV) 
formulae (in ml /min /1.73m2) 
• UDTPA – Glomerular Filtration Rate estimated by 99Tc DTPA not 
corrected to 1.73m2 
• CGF – Glomerular Filtration Rate estimated by Cockcroft Gault 
Formula (in ml /min / 1.73m2) 
• CDTPA – Glomerular Filtration Rate corrected to 1.73m2 body 
surface area  (in ml/ min /1.73m2) 
• ⇓ GFR– Reduction in Glomerular Filtration Rate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Predonation  Post donation 
GFR B.Urea 
(mg%) 
S. Cr. 
(mg%) 
USG L 
(cm) 
USG W 
(cm) 
GFR 
MDRD
B. Urea 
(mg%)
S. Cr. 
(mg%)
USG L 
(cm) 
USG W 
(cm) UDTPA CGF MDRD CDTPA
⇓ GFR Renal Area S. No.
20 0.8 9.5 3.6 87 22 0.8 11.1 5.6 44.09 91.2 86  174.31 -1 47.97 1 
25 1 10.4 3.9 69 23 0.9 10.6 4.5 61.04 102.4 78 240.75 9 62.12 2 
15.8 0.8 NA NA 94 18 0.8 12.4 4.5 61.75 102.8 86 72.24 -8 63.22 3 
20 0.8 9.9 4.8 69 22 0.9 9.8 4.7 45.22 57 68 175.82 -1 53.22 4 
26 1 10.5 3.8 71 18 0.7 10.6 5.1 50.64 135.9 67 154.85 -4 49.22 5 
22.8 0.88 9.6 4.3 100 48.6 1.82 10.8 4.8 27.02 59.1 31 417.99 -69 24.22 6 
21.6 0.88 10 4.4 76 40 1.32 10.5 5.2 45.69 56.8 46 182.05 -30 48.49 7 
28 1 9.9 3.5 64 30 0.9 10.6 4.2 53.71 72.4 71 139.96 7 58.1 8 
22.8 0.9 7.2 2.5 76 39.6 1.2 10.5 5.2 39.03 58.3 54 65.96 -22 44.13 9 
23.4 0.9 9.7 3.6 73 25.2 0.9 10.6 4.5 30.8 82.7 73 206.5 0 32.89 10 
24 0.9 8.9 4 77 20 0.7 10 4.6 DNP 99.2 101 DNP 24 DNP 11 
26 0.8 10.3 4.1 87 23 0.8 12 4.2 DNP 92.4 85 DNP -2 DNP 12 
26.4 0.96 10.6 3.9 67 37.2 1.41 10.1 4.1 38.68 62.7 41 315.22 -26 37.81 13 
24.6 0.99 10.1 3.1 65 39.6 1.36 11.5 4.1 48.81 55.6 45 125.39 -20 49.67 14 
25.8 0.9 9.1 3 114 30.6 1.06 10.6 4.7 61.89 106.4 89 115.93 -35 66.92 15 
22.2 0.99 9.8 3.9 63 25.2 0.95 10.2 4.4 55.84 60.5 65 285.82 2 62.5 16 
23.4 0.99 11.3 4.5 83 33.6 1.26 9.3 4 52.1 60.89 47 253.52 -36 60.89 17 
26.4 0.9 9.3 3.8 101 25.2 0.98 10.4 4.9 53.28 90.7 89 100.28 -12 53.2 18 
23.4 0.97 9.4 3.2 69 24.6 0.9 11.1 3.6 53.6 64.2 74 157.96 5 67.19 19 
22.2 0.97 9.1 4.2 68 33.6 1.22 10 3.2 72.03 40.6 52 93.29 -16 93.69 20 
24.6 0.99 10.8 3.6 102 29.4 1.11 11 3.9 71.3 78.4 87 69.78 -15 73.42 21 
28.8 1.02 10.2 3.6 71 36.6 1.36 11.4 5.2 49.15 59.6 46 81.29 -25 51.22 22 
27.6 0.81 9.2 3.6 124 47.4 1.76 10.5 5.1 53.64 46.4 47 152.24 -77 58 23 
23.4 0.87 8.8 3.2 77 34.2 1.33 10.2 4 42.96 44.9 45 189.8 -32 49.22 24 
24 0.9 10.1 4.1 75 28 0.9 10.2 4.3 54.71 59.4 75 164.72 0 70.63 25 
21 0.8 NA NA 89 21 0.8 12.5 5.5 85.8 58.9 82 198.78 -7 114.18 26 
24 0.9 9.5 4.2 72 24 0.97 10.3 3.92 42.86 65.2 66 73.13 -6 46.34 27 
21.6 0.97 10.1 4.7 72 28.4 1.1 10.2 4.1 48.17 62.6 61 114.59 -11 53.76 28 
24.6 0.97 10.9 3.6 69 26.4 0.97 10.6 3.92 60.87 63.4 65 80.22 -4 67.94 29 
29.4 0.9 10.3 4.3 87 30 0.9 10.3 3.9 52.65 74.8 74 160.65 -13 57.65 30 
S.No Age Age at donation 
 
Sex Post. Duration Recipient AHTN Drugs 
Wt. 
(kg)
Ht. 
(cm) 
BMI 
(kg/m2) BSA (m
2)
SBP 
(mm 
Hg) 
DBP 
(mm 
Hg) 
1 37 35 F 2 Husband - 60 156 24.7 1.59 110 80 
2 30 28 F 2 Husband - 71 155 29.6 1.7 120 70 
3 36 23 F 13 Elder Brother - 67 159 26.5 1.69 110 70 
4 58 55 F 3 Son + 53 150 23.6 1.47 140 80 
5 34 27 F 7 Husband - 76 158 30.4 1.78 110 80 
6 52 43 M 9 Elder Brother Daughter + 88 163 33.1 1.93 130 80 
7 48 40 F 8 Sister + 69 149 31.1 1.63 110 80 
8 48 43 F 5 Daughter - 60 157 24.3 1.6 120 70 
9 36 34 F 2 Daughter - 57 152 24.7 1.53 90 60 
10 43 41 F 2 Daughter - 65 153 27.8 1.62 112 80 
11 35 32 F 3 Elder Brother - 56 150 24.9 1.53 110 70 
12 39 35 F 4 Mother Sister - 62 154 26.1 1.63 122 86 
13 46 45 F 1 Son + 78 155 32.5 1.77 120 80 
14 43 42 F 1 Son - 66 162 25.1 1.7 140 90 
15 27 20 M 7 Father - 58 158 23.2 1.6 110 80 
16 53 50 F 3 Son - 56 155 23.3 1.54 122 80 
17 56 55 M 1 Daughter - 49 161 18.9 1.5 110 100 
18 43 37 M 6 Brother - 66 158 26.4 1.7 150 80 
19 38 37 F 1 Son - 48 146 22.5 1.38 130 60 
20 40 38 F 2 Son - 42 150 18.7 1.33 98 80 
21 40 35 M 5 Mother - 54 178 17 1.68 122 90 
22 39 24 F 15 Brother - 68 154 28.7 1.66 140 80 
23 35 24 M 11 Brother - 56 163 21.1 1.6 120 80 
24 48 39 F 9 Brother - 55 153 23.5 1.51 118 70 
25 37 37 F 0.6 Son - 44 147 20.4 1.34 110 80 
26 45 31 F 14 Unknown - 42 146 19.7 1.3 110 80 
27 46 46 F 0.6 Son - 57 156 23.4 1.6 110 82 
28 32 30 F 2 Brother - 54 155 22.5 1.55 130 80 
29 47 46 F 1 Son + 56 145 26.6 1.55 118 80 
30 40 40 F 0.6 Son - 57 151 25 1.58 124 80 
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